Potency Assay Development
Potency Assay Development is the systematic process of designing, optimizing, and validating analytical methods specifically intended to quantify the biological activity or efficacy of biopesticide active ingredients under controlled conditions.
37
Publications
1.4K
Citations
290
Authors
102
Institutions
Publications per year
2017–2026
15
37
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 464 citations · Full text
Alfonso Lampen, Sandra Siehler, Ursula Ellerbeck et al. · Toxicology and Applied Pharmacology · 1999 · 61 citations
Pharmacy, Pharmacology, Toxicology +14
1–5 of 37
290
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 290
102
Eli Lilly (United States)
Indianapolis, United States
3 h-index
37 publications
9K citations
National Institutes of Health
Bethesda, United States
3 h-index
26 publications
6.3K citations
United States Army Medical Research Institute of Infectious Diseases
Frederick, United States
3 h-index
13 publications
2.3K citations
Seoul National University
Seoul, South Korea
2 h-index
5 publications
130 citations

Chiang Mai University
Chiang Mai, Thailand
2 h-index
3 publications
52 citations
Inserm
Paris, France
2 h-index
5 publications
114 citations
Chulabhorn Graduate Institute
Bangkok, Thailand
2 h-index
2 publications
34 citations
National Institute for Biological Standards and Control
Potters Bar, United Kingdom
2 h-index
15 publications
379 citations
1–8 of 102
3 publications · 55 citations
3
h-index
Repository · 3 publications · 59 citations
3
h-index
2 publications · 34 citations
2
h-index
2 publications · 31 citations
2
h-index
2 publications · 58 citations
2
h-index
1–5